Ms. Przekop is responsible for the development and oversight of the Theradex Quality System, including Quality Assurance, CAPA Management, SOPs, and Training. Prior to joining Theradex, she was Director, Global Quality Management, at J & J. She has 20 + years of pharmaceutical experience.
PRESENTER
(S):
Carol Bognar, Carol Bognar Consulting, LLC, United States
Carol Bognar is currently an Independent GCP Consultant and was formerly a Vice President of GCP Services at the Weinberg Group. She has extensive expertise in QA Services including the performance of over 300 GCP audits and has over 25 years’ experience in healthcare, beginning as a RN.
A QA professional with 8+ years of experience. I have held QA positions in the medical device industry and in the clinical trial industry in both EDC and ePRO. Currently, I am the QA Director at DATATRAK International.
Ms. Przekop is responsible for the development and oversight of the Theradex Quality System, including Quality Assurance, CAPA Management, SOPs, and Training. Prior to joining Theradex, she was Director, Global Quality Management, at J & J. She has 20 + years of pharmaceutical experience.
Description
The face of clinical compliance is changing based on regulatory and technological advances. Long accepted industry standard practices require change. These changes are impacting pharmaceutical companies as well as their service providers. Quality professionals are key partners for ensuring that appropriate industry changes continue to reflect current regulations and protect patient safety. This symposium features clinical quality assurance experts who will address one of these key aspects of our changing environment: regulatory, technology, and service.
Learning Objectives: Define the eClinical environment, and the changing role of quality assurance (QA) with that space Describe how the QA professional should dive in during eClinical audit activities Discuss the GCP audit implications of the new FDA clinical monitoring guidance document Identify how recent regulatory changes and focus are impacting CRO quality assurance, both internally and for sponsors.